We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App

Sysmex Introduces Automated Urinalysis Testing Solutions that Revolutionize Workflow at Medlab Middle East 2023

By LabMedica International staff writers
Posted on 07 Feb 2023
Print article
Image: The UN-Series can automate a lab’s urinalysis work area according to workflow preferences (Photo courtesy of Sysmex)
Image: The UN-Series can automate a lab’s urinalysis work area according to workflow preferences (Photo courtesy of Sysmex)

Sysmex Corporation (Kobe, Japan) is presenting its broad range of medical diagnostics products and solutions in the fields of hematology, urinalysis, haemostasis and flow cytometry at Medlab Middle East 2023.

At Medlab Middle East 2023, taking place 6-9 February in Dubai, Sysmex is showcasing the BloodScience Workcell which smartly combines hematology and haemostasis testing in one interdisciplinary solution – to support physicians in obtaining a more holistic picture of their patients and to improve the workflow in the laboratory. Sysmex’s novel laboratory automation concept consolidates the workflow automation of EDTA and citrate blood sample tubes by combining haematology’s XN-9100 with the new CN track for haemostasis. Both automation lines are physically connected through the tube sorter TS-10 while the capabilities of the Extended IPU facilitate a standardized work area management for hematology and haemostasis. One user can operate this automation platform that harmonizes high workload capacities for citrate and EDTA blood specimens. A safe and completely closed tube system with cap piercing functionality, it effectively reduces the biohazard risk.

Sysmex is also highlighting its modular, integrated clinical flow cytometry system that helps labs efficiently manage sample and data flow, covering the steps from sample preparation through to analysis and reporting. For instance, the programmable PS-10 from Sysmex automates sample preparation steps to match SOPs, adding increased efficiency and standardization for complex and routine flow cytometry applications. The Hettich Rotolavit II-S cell wash centrifuge automatically carries out the routine washing steps when preparing samples for flow cytometry while the award-winning Silent Design of the XN-Series set the standard for the development of this 10-colour flow cytometer for highest-level clinical requirements.

Sysmex is also presenting its urinalysis solutions that can support the diagnosis of common diseases such as urinary tract infections, kidney diseases and others. This includes the UN-Series that can automate the lab’s urinalysis work area according to workflow preferences. With modular components to mix and match, labs can tailor a complete solution that is scalable to their current and future needs, providing a perfect fit while securing your investment. While the UN-Series can cover the complete urinalysis workflow it offers labs maximum flexibility in setting up their desired workflow. Because of its modularity, labs can configure their solution to cover only the parts they require. Whatever the selection, there will be no more hands-on urinalysis as the whole process is automated, and labs get all the results on one screen, with all data centralized in one workstation.

Related Links:
Sysmex Corporation

Gold Supplier
CLIA Processor
Thyroglobulin (Tg) Assay
H. pylori Test
H. pylori Antigen Rapid Test Kit
Hematology Reagents
Hematology Reagents

Print article


Clinical Chem.

view channel
Image: Brief schematic diagram of the detection principle and method (Photo courtesy of CAS)

Rapid, Non-Invasive Method Diagnoses Type 2 Diabetes by Sniffing Urinary Acetone

Over 90% of diabetes cases are attributed to Type 2 diabetes (T2D), a prevalent metabolic condition that is expected to impact 380 million individuals globally by 2025. Despite being highly accurate, the... Read more

Molecular Diagnostics

view channel
Image: Researchers have identified the origin of subset of autoantibodies that worsen lupus (Photo courtesy of Pexels)

Lupus Biomarker Testing Could Help Identify Patients That Need Early and Aggressive Treatment

Systemic lupus erythematosus (SLE) is an autoimmune disease that occurs when the body's antibodies, which usually protect against infections, attack healthy cells and proteins. These autoantibodies can... Read more


view channel
Image: A genetic test could guide the use of cancer chemotherapy (Photo courtesy of Pexels)

Genetic Test Predicts Whether Bowel Cancer Patients Can Benefit From Chemotherapy

Late-stage bowel cancer patients usually undergo a series of chemotherapies and targeted medicines for cancer treatment. However, the responses to the last-line chemotherapy treatment trifluridine/tipiracil... Read more


view channel
Image: Use of DBS samples can break barriers in hepatitis C diagnosis and treatment for populations at risk (Photo courtesy of Pexels)

DBS-Based Assay Effective in Hepatitis C Diagnosis and Treatment for At Risk Populations

In a bid to eliminate viral hepatitis as a public health threat by 2030, the World Health Organization (WHO) has put forth a proposed strategy. To this end, researchers at the Germans Trias i Pujol Research... Read more


view channel
Image: New research has opened a path for fast and accurate cancer diagnosis (Photo courtesy of Imagene)

AI-Based Image Analysis Software Profiles Cancer Biomarkers in Real Time

Lung cancer is the most widespread type of cancer worldwide, resulting in approximately 1.76 million fatalities annually. Non-small cell lung cancer (NSCLC) accounts for 85% of all lung cancer diagnoses... Read more


view channel
Image: Live view of non-fluorescent specimens using the glowscope frame (Photo courtesy of Winona State University)

Device Converts Smartphone into Fluorescence Microscope for Just USD 50

Fluorescence microscopes are utilized to examine specimens labeled with fluorescent stains or expressing fluorescent proteins, like those tagged with green fluorescent protein. However, since these microscopes... Read more


view channel
Image: The global antimicrobial resistance diagnostics market size is expected to reach USD 5.7 billion by 2028 (Photo courtesy of Pexels)

Global Antimicrobial Resistance Diagnostics Market Driven by Increasing Hospital-Acquired Infections

Antimicrobial drugs are intended to counteract the harmful effects of microbes and promote a healthy life. However, their excessive use can result in the development of resistance, commonly referred to... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.